Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,342 | -$17,662 | -$16,978 | -$9,530 |
| Dep. & Amort. | $50 | $53 | $81 | $146 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,582 | $1,563 | $1,714 | $0 |
| Change in WC | $6,163 | $122 | -$1,000 | -$2,550 |
| Other Non-Cash | -$3 | -$675 | -$238 | $992 |
| Operating Cash Flow | -$15,550 | -$16,599 | -$16,421 | -$10,942 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,841 | -$17,623 | -$37,605 | -$11,241 |
| Inv. Sales/Matur. | $37,479 | $35,366 | $55,728 | $19,971 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $19,638 | $17,743 | $18,123 | $8,730 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,851 | $0 | $0 | -$13 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2,851 | $0 | $0 | -$13 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6,939 | $1,144 | $1,702 | -$2,225 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,714 | $19,570 | $17,868 | $19,708 |
| End Cash | $27,653 | $20,714 | $19,570 | $17,483 |
| Free Cash Flow | -$15,550 | -$16,599 | -$16,421 | -$10,942 |